Tano, Charlie M.

HRN: 28-56-41  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2026
CEFTRIAXONE 1G (VIAL)
02/13/2026
02/20/2026
IV
2g
OD
Lacerated Wound And Abrasions
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: